In a major policy shift, the U.S. Food and Drug Administration is reconsidering restrictions on several controversial peptides, including trending compounds like BPC 157 and Melanotan II. The move comes as demand for Tanning Injections: Risks, Side Effects, and Precautions You Should Avoid Using Nasal Tanning Sprays Emerging Threat: Melanotan, Repackaging, and Online Sales Melanotan 2 Reviews, Clinical Trials, and Safety An FDA Reversal on Peptides Could Open the Market to Unsafe Drugs ProPublica